Hydroxychloroquine shortages among patients with systemic lupus erythematosus during the COVID-19 pandemic: experience of the Systemic Lupus International Collaborating Clinics

Ann Rheum Dis. 2021 Feb;80(2):1-2. doi: 10.1136/annrheumdis-2020-218164. Epub 2020 Jun 25.
No abstract available

Keywords: epidemiology; hydroxychloroquine; lupus erythematosus; systemic.

Publication types

  • Letter

MeSH terms

  • Antirheumatic Agents / supply & distribution*
  • Antirheumatic Agents / therapeutic use
  • COVID-19 / drug therapy*
  • Health Services Accessibility
  • Humans
  • Hydroxychloroquine / supply & distribution*
  • Hydroxychloroquine / therapeutic use
  • Lupus Erythematosus, Systemic / drug therapy*
  • SARS-CoV-2
  • Surveys and Questionnaires

Substances

  • Antirheumatic Agents
  • Hydroxychloroquine

Supplementary concepts

  • COVID-19 drug treatment